Marksans Pharma Limited has informed the Exchange about Schedule of meet
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma Limited has informed the exchanges that its officials will participate in an investor and analyst conference on September 23, 2025, at 10:00 A.M. IST. The event is the Pharma & Healthcare Conference hosted by DAM Capital, to be held physically at Trident BKC. The company clarified that no unpublished price-sensitive information (UPSI) will be shared during the interactions. The intimation has been filed under Regulation 30(6) of the Listing Regulations, with the standard note that the schedule may change due to exigencies.
This is a routine compliance disclosure with no material price action expected. Investors and analysts may get useful insights into the company's outlook in the pharma sector, which could subtly influence sentiment around the stock.